Literature DB >> 10858264

Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.

J J Kohler1, L Pathangey, A Hasona, A Progulske-Fox, T A Brown.   

Abstract

We have previously shown that Salmonella enterica serovar Typhimurium expressing the hagB hemagglutinin gene from Porphyromonas gingivalis can induce primary and recall immune responses in serum and secretions in mice; however, the longevity of memory induced by oral Salmonella carriers has not been adequately demonstrated. In this study, we examined the capacity of mice to mount a recall response 52 weeks after primary immunization. Recall responses were seen in serum immunoglobulin G (IgG) and IgA following boosting at week 52, and in most cases, they were equal to or greater than the primary responses. Significant mucosal IgA recall responses in saliva and vaginal wash were also detected following boosting at week 52. In addition, there was a considerable residual response in secretions at week 51, prior to boosting. These results indicate that oral Salmonella vectors can induce long-term memory to recombinant HagB and are particularly effective at inducing long-lasting mucosal responses as well as at inducing the capacity for mucosal recall responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858264      PMCID: PMC101775          DOI: 10.1128/IAI.68.7.4370-4373.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

Authors:  J X Bao; J D Clements
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.

Authors:  J Katz; K P Black; S M Michalek
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains.

Authors:  J E Galán; K Nakayama; R Curtiss
Journal:  Gene       Date:  1990-09-28       Impact factor: 3.688

6.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin.

Authors:  G Hajishengallis; S M Michalek; M W Russell
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

8.  Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.

Authors:  J J Kohler; L B Pathangey; S R Gillespie; T A Brown
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.

Authors:  D M Dusek; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium.

Authors:  D M Dusek; A Progulske-Fox; J Whitlock; T A Brown
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more
  16 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase.

Authors:  C Jespersgaard; G Hajishengallis; Y Huang; M W Russell; D J Smith; S M Michalek
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B.

Authors:  Ping Zhang; Michael Martin; Suzanne M Michalek; Jannet Katz
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.

Authors:  Beatriz del Rio; Jesus Lajara Fuente; Vera Neves; Raymond Dattwyler; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  Vaccine       Date:  2010-08-08       Impact factor: 3.641

6.  Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis.

Authors:  Deborah E Dietrich; Xiangjun Xiao; Deborah V Dawson; Myriam Bélanger; Hua Xie; Ann Progulske-Fox; Kim A Brogden
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

7.  Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.

Authors:  Beatriz del Rio; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

8.  Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.

Authors:  Latha Pathangey; James J Kohler; Ryutaro Isoda; Thomas A Brown
Journal:  Vaccine       Date:  2009-03-03       Impact factor: 3.641

9.  Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.

Authors:  Beatriz del Rio; Raymond J Dattwyler; Miguel Aroso; Vera Neves; Luciana Meirelles; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2008-07-16

10.  Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis.

Authors:  Ping Zhang; Michael Martin; Qiu-Bo Yang; Suzanne M Michalek; Jannet Katz
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.